Genomic scarring score predicts the response to PARP inhibitors in non-small cell lung cancer
Katerina Tsilingiri(Biomedical Research Foundation of the Academy of Athens), Apostolos Klinakis(Academy of Athens)
Cited by 0
Related Papers
Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer
|Cellular and Molecular Life Sciences|2023|22
Notch controls urothelial integrity in the mouse bladder
|JCI Insight|2020|16